Basic Information
Basic information for UCA1-230-69aa
Peptide Name UCA1-230-69aa
Genome Position chr19:15829191-15829338,15831208-15831266[+]
Species Human
Peptide Sequence MLDTWCQNLGQGDSFVRPAPCPGPHSVKRSTCDLGSSDQPKEHLTNFKSGSLELWLKALWLTPSQISSA
Peptide Length 69
Unique No (UCA1-204-69aa,UCA1-220-69aa,UCA1-232-69aa)
Grand Average of Hydropathicity -0.4435
Relative Molecular Mass 8781.65
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000645821;UCA1-230
Transcript Length 594
Coding Ability 0.6364
DNA Sequence Corresponding to Peptide ATGCTTGACACTTGGTGCCAAAATCTGGGCCAGGGGGACTCCTTCGTGAGACCGGCCCCCTGTCCTGGCCCTCATTCCGTGAAGAGATCCACCTGCGACCTCGGGTCCTCAGACCAGCCCAAGGAACATCTCACCAATTTCAAATCGGGGTCCCTGGAGCTCTGGCTCAAAGCTCTCTGGCTGACTCCTTCCCAGATCTCCTCGGCT
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :